Bayer's subsidiary AskBio received approval from the U.S. drug regulator to accelerate the development of its investigational gene therapy to treat moderate-stage Parkinson's disease.

This February, Morris-Simon and her colleagues at Bayer are leveraging Heart Month and Black History Month as an opportunity ...

In the United States alone, 104 million people are at risk of cardiovascular disease, and in a study of those that ...

Recent studies suggest that current cardiovascular risk assessment methods may be inadequate and call for a more personalized approach. Tools lik ...

With the recent 125th anniversary of aspirin’s discovery, new research is shedding light on innovative approaches to ...

Many moms who are expecting for the first time ask whether it's safe to take aspirin during pregnancy. The answer isn't ...

AB-1002 is an investigational gene therapy for the treatment of adults with non-ischemic cardiomyopathy and New York Heart Association (NYHA) Class III heart failure symptoms GenePHIT is a clinical ...

James Wong had always dismissed the idea aspirin was beneficial to plants. But digging into the science brought some surprises ...

Millions of Americans take aspirin daily despite new health warnings.

Bayer is committed to advancing treatment in prostate cancer care, showcasing new analyses from its comprehensive clinical trial program for NUBEQA ® (darolutamide), which includes the ARANOTE, ...

Bayer is worried about your heart health. | Older millennials, take note: Bayer is worried about your heart health. The drugmaker set out its concerns in an ad for aspirin, showing how people are ...